Plain-English translation of NCT07361198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a minimally invasive procedure called genicular artery embolization, which uses a thin catheter to identify and reduce blood flow to abnormal blood vessels in the arthritic knee joint. The procedure is performed in an imaging suite under local anesthesia and targets areas of inflammation that may be causing chronic knee pain. Researchers want to see if this treatment can safely reduce pain in people with moderate-to-severe knee arthritis who haven't found relief with medications, physical therapy, or injections.
Knee arthritis causes severe, ongoing pain for many people, and some patients don't get enough relief from standard treatments. This trial explores whether blocking blood flow to inflamed areas of the knee joint might be a new option for people with chronic arthritis pain.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo a catheter procedure in an imaging suite under local anesthesia, where doctors thread a thin tube through an artery to target abnormal blood vessels in your knee. Before the procedure and at scheduled follow-up visits over two years, you will have clinical assessments and imaging to track your pain levels and monitor for any side effects. The study focuses on understanding whether the procedure is safe and technically feasible, with close monitoring throughout the two-year follow-up period.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
Czechia